Synergistic activity of 1-(1-naphthylmethyl)-piperazine with ciprofloxacin against clinically resistant Staphylococcus aureus, as determined by different methods

Letters in Applied Microbiology

Volumn 52, Issue 4, 2011, Pages 372-378

  Li, L ^a   Li, Z ^a   Guo, N ^a   Jin, J ^a   Du, R ^b   Liang, J ^a   Wu, X ^a   Wang, X ^a   Liu, M ^a   Jin, Q ^c   Yu, L ^a  

^a JILIN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

1 (1 naphthylmethyl) piperazine; Antimicrobial activity; Ciprofloxacin; Methicillin resistant Staphylococcus aureus; Synergy

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA;

1-(1-NAPHTHYLMETHYL)-PIPERAZINE; ANTI-MICROBIAL ACTIVITY; CIPROFLOXACIN; CLINICAL ISOLATES; FLUOROQUINOLONES; IN-VITRO; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RESISTANT STAPHYLOCOCCUS AUREUS; SYNERGISTIC ACTIVITY; SYNERGY;

STRAIN;

1 (1 NAPHTHYLMETHYL)PIPERAZINE; CIPROFLOXACIN; PIPERAZINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; INHIBITOR; SYNERGISM;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG POTENTIATION; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 79952516381     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2011.03010.x     Document Type: Article

References (29)

1. Aeschlimann, J.R., Dresser, L.D., Kaatz, G.W. and Rybak, M.J. (1999) Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 43, 335-3340.
2. Amaral, L., Viveiros, M. and Molnar, J. (2004) Antimicrobial activity of phenothiazines. In Vivo 18, 725-731.
3. Bina, X.R., Philippart, J.A. and Bina, J.E. (2009) Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J Antimicrob Chemother 63, 103-108.
4. Bohnert, J.A. and Kern, W.V. (2005) Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 49, 849-852.
5. Clark, N.M., Hershberger, E., Zervosc, M.J. and Lynch, J.P. 3rd (2003) Antimicrobial resistance among gram-positive organisms in the intensive care unit. Curr Opin Crit Care 9, 403-412.
6. Clinical and Laboratory Standards Institute (CLSI) (2009) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-eighth Edition, Approved Standard M7-A8. Wayne, PA, USA: CLSI.
7. Davis, R., Markham, A. and Balfour, J.A. (1996) Ciprofloxacin, an updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs 51, 1019-1074.
8. Gibbons, S., Oluwatuyi, M. and Kaatz, G.W. (2003) A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 51, 13-17.
9. Guo, N., Liu, J., Wu, X., Bi, X., Meng, R., Wang, X., Xiang, H., Deng, X. et al. (2009) Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. J Med Microbiol 58, 1074-1079.
10. Jacqueline, C., Navas, D., Batard, E., Miegeville, A.F., Le Mabecque, V., Kergueris, M.F., Bugnon, D., Potel, G. et al. (2005) In vitro and In vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49, 45-51.
11. Khan, I.A., Mirza, Z.M., Kumar, A., Verma, V. and Qazi, G.N. (2006) Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 50, 810-812.
12. Koenig, R. (2008) Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination. Science 319, 894-897.
13. Kumar, A., Khan, I.A., Koul, S., Koul, J.L., Taneja, S.C., Ali, I., Ali, F., Sharma, S. et al. (2008) Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother 61, 1270-1276.
14. Kvist, M., Hancock, V. and Klemm, P. (2008) Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol 74, 7376-7382.
15. Marquez, B. (2005) Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87, 1137-1147.
16. Meletiadis, J., Mouton, J.W., Meis, J.F. and Verweij, P.E. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 47, 106-117.
17. Nguyen, H.M. and Graber, C.J. (2010) Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J Antimicrob Chemother 65, 24-36.
18. Oo, T.Z., Cole, N., Garthwaite, L., Willcox, M.D. and Zhu, H. (2010) Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection. J Antimicrob Chemother 65, 1243-1251.
19. Pannek, S., Higgins, P.G., Steinke, P., Jonas, D., Akova, M., Bohnert, J.A., Seifert, H. and Kern, W.V. (2006) Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide. J Antimicrob Chemother 57, 970-974.
20. Paulsen, I.T., Firth, M. and Skurray, R.A. (1997) Resistance to antimicrobial agents other than-lactams. In The Staphylococci in Human Disease eds Crossley, K.B. and Archer, G.L. pp. 175-212. New York: Churchill Livingstone.
21. Périchon, B. and Courvalin, P. (2006) Synergism between β-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon. Antimicrob Agents Chemother 50, 3622-3630.
22. Piddock, L.J. (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19, 382-402.
23. Prichard, M.N., Prichard, L.E. and Shipman, C. Jr (1993) Strategic design and three-dimensional analysis of antiviral drug combinations. Antimicrob Agents Chemother 37, 540-545.
24. Santos, A.O., Ueda-Nakamura, T., Dias Filho, B.P., Veiga Junior, V.F., Pinto, A.C. and Nakamura, C.V. (2008) Antimicrobial activity of Brazilian copaiba oils obtained from different species of the Copaifera genus. Mem Inst Oswaldo Cruz 103, 277-281.
25. Stermitz, F.R., Cashman, K.K., Halligan, K.M., Morel, C., Tegos, G.P. and Lewis, K. (2003) Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. Bioorg Med Chem Lett 13, 1915-1918.
26. Sun, S., Li, Y., Guo, Q., Shi, C., Yu, J. and Ma, L. (2008) In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother 52, 409-417.
27. Tattevin, P., Basuino, L. and Chambers, H.F. (2009) Subinhibitory fluoroquinolone exposure selects for reduced β-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res Microbiol 160, 187-192.
28. Thomson, K.S. and Sanders, C.C. (1998) The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones. J Antimicrob Chemother 42, 179-187.
29. Vidaillac, C., Guillon, J., Arpin, C., Forfar-Bares, I., Ba, B.B., Grellet, J., Moreau, S., Caignard, D.H. et al. (2007) Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus. Antimicrob Agents Chemother 51, 831-838.